AIM: The aim of this study was to evaluate the impact of admission anemia on in-hospital, one-month, and one-year mortality in patients from the Middle East with acute coronary syndrome (ACS). METHODS: Data were analyzed from 7922 consecutive patients admitted to hospitals throughout six Middle-Eastern countries with the final diagnosis of ACS, as part of Gulf RACE II (Registry of Acute Coronary Events II). Anemia at admission was defined according to the World Health Organization definition (<13 g/dL in men and <12 g/dL in women). Analyses were conducted using univariate and multivariate statistical techniques. RESULTS: The median age of the cohort was 56 (48-65) years, with the majority being male (79%). Anemia at admission was present in 2241 patients (28%). Patients with anemia were more likely to have in-hospital complications including heart failure, recurrent ischemia, re-infarction, cardiogenic shock, stroke, and major bleed. Even after adjustment, anemia was still associated with mortality at in-hospital (odds ratio [OR]=1.71, 95% confidence interval [CI], 1.34-2.17; P<0.001), at one-month (OR=1.34, 95% CI, 1.06-1.71; P=0.016), and at one-year (OR=1.22, 95% CI, 1.01-1.49; P=0.049) post-admission with ACS. CONCLUSIONS: Admission anemia in patients with ACS from six Middle-Eastern countries was strongly associated with mortality at in-hospital, one-month, and at one-year. Hence, admission anemia must be considered in the initial risk assessment of ACS patients along with other risk scores.
AIM: The aim of this study was to evaluate the impact of admission anemia on in-hospital, one-month, and one-year mortality in patients from the Middle East with acute coronary syndrome (ACS). METHODS: Data were analyzed from 7922 consecutive patients admitted to hospitals throughout six Middle-Eastern countries with the final diagnosis of ACS, as part of Gulf RACE II (Registry of Acute Coronary Events II). Anemia at admission was defined according to the World Health Organization definition (<13 g/dL in men and <12 g/dL in women). Analyses were conducted using univariate and multivariate statistical techniques. RESULTS: The median age of the cohort was 56 (48-65) years, with the majority being male (79%). Anemia at admission was present in 2241 patients (28%). Patients with anemia were more likely to have in-hospital complications including heart failure, recurrent ischemia, re-infarction, cardiogenic shock, stroke, and major bleed. Even after adjustment, anemia was still associated with mortality at in-hospital (odds ratio [OR]=1.71, 95% confidence interval [CI], 1.34-2.17; P<0.001), at one-month (OR=1.34, 95% CI, 1.06-1.71; P=0.016), and at one-year (OR=1.22, 95% CI, 1.01-1.49; P=0.049) post-admission with ACS. CONCLUSIONS: Admission anemia in patients with ACS from six Middle-Eastern countries was strongly associated with mortality at in-hospital, one-month, and at one-year. Hence, admission anemia must be considered in the initial risk assessment of ACS patients along with other risk scores.
Authors: C P Cannon; A Battler; R G Brindis; J L Cox; S G Ellis; N R Every; J T Flaherty; R A Harrington; H M Krumholz; M L Simoons; F J Van De Werf; W S Weintraub; K R Mitchell; S L Morrisson; R G Brindis; H V Anderson; D S Cannom; W R Chitwood; J E Cigarroa; R L Collins-Nakai; S G Ellis; R J Gibbons; F L Grover; P A Heidenreich; B K Khandheria; S B Knoebel; H L Krumholz; D J Malenka; D B Mark; C R Mckay; E R Passamani; M J Radford; R N Riner; J B Schwartz; R E Shaw; R J Shemin; D B Van Fossen; E D Verrier; M W Watkins; D R Phoubandith; T Furnelli Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094
Authors: Melissa Rousseau; Raymond T Yan; Mary Tan; Charles J Lefkowitz; Amparo Casanova; David Fitchett; Sanjit S Jolly; Anatoly Langer; Shaun G Goodman; Andrew T Yan Journal: Am J Cardiol Date: 2010-10-01 Impact factor: 2.778
Authors: Marc S Sabatine; David A Morrow; Robert P Giugliano; Paul B J Burton; Sabina A Murphy; Carolyn H McCabe; C Michael Gibson; Eugene Braunwald Journal: Circulation Date: 2005-04-11 Impact factor: 29.690
Authors: Erik Lipsic; Iwan C C van der Horst; Adriaan A Voors; Peter van der Meer; Maarten W N Nijsten; Wiek H van Gilst; Dirk J van Veldhuisen; Felix Zijlstra Journal: Int J Cardiol Date: 2005-04-20 Impact factor: 4.164
Authors: Erdal Cavusoglu; Vineet Chopra; Amit Gupta; Luther T Clark; Calvin Eng; Jonathan D Marmur Journal: Am J Cardiol Date: 2006-06-28 Impact factor: 2.778
Authors: Nana Valeur; Olav Wendelboe Nielsen; John J V McMurray; Christian Torp-Pedersen; Lars Køber Journal: Eur J Heart Fail Date: 2006-05-05 Impact factor: 15.534
Authors: Eugenia Nikolsky; Eve D Aymong; Amir Halkin; Cindy L Grines; David A Cox; Eulogio Garcia; Roxana Mehran; James E Tcheng; John J Griffin; Giulio Guagliumi; Thomas Stuckey; Mark Turco; David A Cohen; Manuela Negoita; Alexandra J Lansky; Gregg W Stone Journal: J Am Coll Cardiol Date: 2004-08-04 Impact factor: 24.094
Authors: Sunil V Rao; James G Jollis; Robert A Harrington; Christopher B Granger; L Kristin Newby; Paul W Armstrong; David J Moliterno; Lauren Lindblad; Karen Pieper; Eric J Topol; Jonathan S Stamler; Robert M Califf Journal: JAMA Date: 2004-10-06 Impact factor: 56.272
Authors: David H Shu; Thomas P P Ransom; Colleen M O'Connell; Jafna L Cox; Stephanie M Kaiser; Shirl A Gee; Richard C Rowe; Ehud Ur; Syed Ali Imran Journal: Cardiovasc Diabetol Date: 2006-04-07 Impact factor: 9.951
Authors: Faisal Alsayegh; Moh A Alkhamis; Fatima Ali; Sreeja Attur; Nicholas M Fountain-Jones; Mohammad Zubaid Journal: PLoS One Date: 2022-01-24 Impact factor: 3.240